Merck Enflonsia wins ACIP backing for RSV protection in infants under 8 months Ruchika Sharma29 Jun 2025 1:15 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Centers for Disease Control and Prevention (CDC)...
Enlicitide Decanoate Promising as Oral PCSK9 Inhibitor in Hyperlipidemia in Phase 3 trials Dr. Kamal Kant Kohli21 Jun 2025 7:30 AM ISTPhase 3 trials have demonstrated that enlicitide decanoate significantly reduces LDL cholesterol, showing strong potential as an oral PCSK9 inhibitor...
FDA Approves Clesrovimab to Prevent RSV in Infants Dr. Kamal Kant Kohli20 Jun 2025 9:00 PM ISTThe FDA has approved clesrovimab, marketed as Enflonsia, for the prevention of RSV lower respiratory tract disease in neonates and infants during...
Phase 3 trial initiated for Ifinatamab Deruxtecan in Pretreated Metastatic Castration-Resistant Prostate Cancer: Merck, Daiichi Sankyo Ruchika Sharma19 Jun 2025 10:00 AM ISTBasking Ridge: Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating...
Merck Keytruda approved by USFDA for Advanced Head and Neck Cancer Ruchika Sharma15 Jun 2025 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Merck begins Phase 3 study for Dengue vaccine candidate Ruchika Sharma13 Jun 2025 11:00 AM ISTMerck is establishing a program of clinical trials for V181, including conducting trials globally, in places where dengue is a significant health...
Merck RSV antibody Enflonsia gets USFDA okay for infants Ruchika Sharma10 Jun 2025 11:06 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA)...
Merck posts positive phase 3 trials results evaluating Enlicitide Decanoate in adults with Hyperlipidemia Ruchika Sharma10 Jun 2025 9:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the first two of three...
Merck, Daiichi Sankyo withdraw US appication for patritumab deruxtecan for advanced or metastatic EGFR-mutated non-small cell lung cancer Ruchika Sharma31 May 2025 3:18 PM ISTRahway: Daiichi Sankyo and Merck, known as MSD outside of the United States and Canada, have announced that the Biologics License Application...
Merck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma Ruchika Sharma15 May 2025 11:45 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug Administration...
Integrated digital health gateway ekincare raises investment from MSD IDEA Studio Asia Pacific Ruchika Sharma29 April 2025 1:30 PM ISTTo date, ekincare has raised a total funding of USD22M since 2015.
Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion Ruchika Sharma27 April 2025 4:00 PM ISTBengaluru: Merck KGaA, a science and technology company, is in late-stage negotiations to buy SpringWorks Therapeutics, a US based...
